Support for adding tofacitinib to methotrexate in patients with RA
Results of the ORAL Strategy trial suggest that tofacitinib given in combination with methotrexate, but not alone, is noninferior to adalimumab plus methotrexate for the treatment of patients with rheumatoid arthritis and an inadequate response to methotrexate.
Headlines from across medwireNews
Beyond the news
medwireNews brings you news and conference reports from the ESMO 2016 Congress, held in Copenhagen, Denmark.
Click through to read the full reports of the latest research.
Highlights from the 1st conference of the European Academy of Neurology in Berlin, Germany.
Click through to read research news from the conference.
medwireNews is an established provider of authoritative, timely and independent medical news. We value your feedback and encourage you to contact us to make medwireNews.com your preferred medical news resource.
Hospitalised patient_woman/© WavebreakMediaMicro / Fotolia, DNA background/© Leigh Prather / Fotolia, David Hyman/© Shreeya Nanda, pills, ESMO 2016 flags_enhanced/© Lynda Williams, Children with medical team/© Christopher Futcher, Brandenburg Gate/© Nikada/iStock, Lucy Piper, Lynda Williams, Eleanor McDermid, Shreeya Nanda, Claire Barnard, Alison Chapman, Kamran Ahmad